Retrospective Study of Hepatotoxicity of Gemcitabine （Gemzar®）as First-line Chemotherapy in Non-Small Cell Lung Cancer
碩士 === 國立臺灣大學 === 臨床藥學研究所 === 93 === Gemcitabine (Gemzar®) is one of the standard drugs used in patients with advanced non-small cell lung cancer. Compared with other cytotoxic agents, gemcitabine displayed minimal toxicity. Hepatotoxicity occurred frequently (about 20~50%) and was manifest as a tra...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2005
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/61838921972542661124 |